Second, our work highlights the critical balance involved in regulating inflammatory machinery during SARS-CoV infection, and suggests that inhibition of TNFα or PP1 signaling may represent viable avenues for future investigations into effective pharmaceutical therapies. Here, TNF is linked to severe acute respiratory syndrome.